# Eurofins Dr. Specht International GmbH – FDA Inspection, Feb 2, 2018

Source: https://www.keypedia.com/records/fda_inspections/eurofins-dr-specht-international-gmbh/2e7ad322-15a7-41a1-a994-90f9f0aa76a9
Source feed: FDA_Inspections

> FDA inspection 1039985 of Eurofins Dr. Specht International GmbH, February 02, 2018. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1039985
- Company Name: Eurofins Dr. Specht International GmbH
- Inspection Date: 2018-02-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 841943 - 2013-07-10](https://www.keypedia.com/records/fda_inspections/eurofins-dr-specht-international-gmbh/1b063d23-24ce-4be0-a633-6e71a632a479)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/djamila-harouaka/106cef03-a214-4184-963a-6580d3bd7fd9)
- [FDA Associated Person](https://www.keypedia.com/people/qin-xu/176a88a7-a11e-4374-a64a-378806e76d84)

Company: https://www.keypedia.com/companies/eurofins-dr-specht-international-gmbh/2eb18149-9fdf-4790-881b-911d9d5c3090

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
